CORONA Remedies IPO Allotment Status: Check on BSE, NSE, Bigshare

The CORONA Remedies IPO allotment is scheduled for December 11, 2025, after a very strong subscription build-up over the three days of the issue. Investors showed a modest start on Day 1 but turned extremely aggressive by Day 3, especially in institutional and HNI categories. This blog will help you check your allotment status step by step and quickly understand subscription trends, GMP moves, and what to expect on listing day.​

Important Dates

• Allotment Date: December 11, 2025
• Initiation of Refunds: December 12, 2025
• Credit of Shares to Demat: December 12, 2025
• Listing Date: December 15, 2025

How to Check CORONA Remedies IPO Allotment Status

Method 1: Check on BSE

• Open the BSE IPO allotment page: https://www.bseindia.com/investors/appli_check.aspx
• Choose “Equity” as the issue type.
• From the dropdown, select “CORONA Remedies Limited”.
• Enter your application number or your PAN, as asked on the page.
• Type the captcha code shown and click “Search” to see if shares are allotted or not.

Method 2: Check on NSE

• Go to the NSE IPO allotment status page: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• Click on "Equity & SME IPO bid details."​
• In the list, select “CORONA Remedies Limited”.​
• Enter your PAN or application number and any other details the page asks for.
• Submit to view whether you have received full, partial, or zero shares.

Method 3: Check on Registrar (Bigshare)

• Open the registrar’s official website: https://www.bigshareonline.com/ipo_Allotment.html
• Pick any one of the three servers shown.
• Select “Corona Remedies” from the public offer list.
• Enter your application number, beneficiary ID, or PAN.
• Solve the captcha and click ‘Search’.

CORONA Remedies IPO Subscription Details

Source: Chittorgarh

• Day 1 looked cautious with sub-1X total bids, but demand surged sharply from Day 2 and exploded on Day 3, led by QIBs and HNIs, while retail also crossed 30 times.​
• Such heavy oversubscription means the probability of allotment for a single retail application is low, especially in the RII bucket.​
• For small retail investors, this kind of subscription often translates into a lottery-type outcome, where many valid applications end up with zero shares despite applying correctly.

CORONA Remedies IPO GMP Update

The grey market premium for CORONA Remedies hovered roughly in the ₹260-₹295 range through the issue, implying an expected listing gain of about 24-28%. The premium dipped slightly on Day 1, recovered on Day 2, and inched up around the closing and allotment dates, suggesting broadly positive but shifting sentiment as fresh subscription numbers and market conditions came in.

Disclaimer: GMP is an unofficial, unregulated market indicator, highly volatile, and should not be treated as a sure-shot signal of listing price or profit.​

What’s Next After Allotment?

If shares are allotted

• Your allotted share count will show on the BSE / NSE / registrar allotment status pages once the basis of allotment is finalised.​
• On or around December 12, 2025, the same shares should reflect in your demat account with your broker.​
• If you applied for more lots but got only some of them, the blocked amount for unallotted shares will be released back to your bank or UPI, while you keep the allotted shares.
• After that, you simply wait for the listing on December 15, 2025, and then decide whether to hold for the long term or book any listing gains or losses as per your plan.​

If shares are not allotted

• Your blocked amount or UPI mandate will be released or unblocked, usually starting from December 12, 2025, as per the refund schedule.​
• You will not receive any shares in your demat account, and your holding in CORONA Remedies will remain zero until you buy from the secondary market.
• You can still purchase the stock after listing on the NSE and BSE, once trading begins on December 15, 2025, at the then market price.​
• Extremely high oversubscription, such as what we saw in this IPO, naturally lowers the odds of allotment for many genuine retail applications.

For detailed information, visit CORONA Remedies’ official IPO page at INDmoney.

Final Word

CORONA Remedies has seen a powerful subscription response across investor categories, strong GMP signals, and an issue structure that is fully priced but backed by high growth and solid return ratios, so allotment has turned into a real scarcity event for many retail applicants. Treat the allotment outcome as just one step: what really matters is whether the business quality, valuation, and your own risk appetite match, so you can take a calm call on holding or buying after listing instead of simply chasing short-term buzz.​

For more IPOs, check INDmoney’s IPO tracker here.

Disclaimer

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. The securities are quoted as an example and not as a recommendation. This is nowhere to be considered as advice, recommendation, or solicitation of an offer to buy or sell or subscribe for securities. INDStocks SIP / Mini Save is a SIP feature that enables Customer(s) to save a fixed amount on a daily basis to invest in Indian stocks. INDstocks Private Limited (formerly known as INDmoney Private Limited) 616, Level 6, Suncity Success Tower, Sector 65, Gurugram, 122005, SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428. Refer to https://indstocks.com/pricing?type=indian-stocks; https://www.indstocks.com/page/indian-stocks-sip-terms-and-condition for further details.